RecruitingNot applicableNCT06708572
Evaluation of the Use of Granulocyte Colony Stimulating Factor (GCSF) in Post Kasai Type 3 Biliary Atresia
Studying Biliary atresia and associated disorders
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Liver Institute, Egypt
- Intervention
- Granulocyte Colony-Stimulating Factor(drug)
- Enrollment
- 40 enrolled
- Eligibility
- 1 years · All sexes
- Timeline
- 2024 – 2026
Study locations (1)
- National Liver Institute, Cairo, Menofia Governorate, Egypt
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06708572 on ClinicalTrials.gov